MIT researchers have created an inexpensive method to screen for millions of different biomolecules (DNA, proteins, etc.) in a single sample-a technology that could make possible the development of low-cost clinical bedside diagnostics.
The work, based on tiny customizable particles, could also be used for disease monitoring, drug discovery or genetic profiling. Even though the particles are thinner than the width of a human hair, each is equipped with a barcoded ID and one or more probe regions that turn fluorescent when they detect specific targets in a test sample.
Using a new, extremely versatile technique, the researchers can produce a "virtually unlimited" array of particles to test for DNA, RNA, proteins and other biomolecules, said Daniel Pregibon, a graduate student in chemical engineering at MIT.
Pregibon is the lead author of a paper on the work that will appear in the journal Science.
He and co-author Patrick Doyle, the Doherty Associate Professor of Chemical Engineering, believe their particles could become an effective and inexpensive way to perform medical diagnostic tests at a patient's bedside.
Current testing methods are cost-prohibitive for bedside use, Pregibon said. The MIT particles are inexpensive to manufacture, and their results are as accurate, if not more so, than the results from more expensive systems, he said.
The particles offer a new way to do "multiplexed detection"-testing a single sample for multiple targets. In the laboratory...
Whole article: "www.sciencedaily.com":[ http://www.sciencedaily.com/releases/2007/03/070308220914.htm]
New Micro-chip Detector Will Be Able To Detect Thousands Of Substances -
A Sandia National Laboratories research team is developing a new type of electrochemical sensor that uses a unique surface chemistry to reliably and accurately detects thousands of differing biomolecules on a single platform (4.5.2007)
Stress-Induced Heart Disease Controlled By Tiny Molecule -
A tiny snippet of RNA, a chemical cousin of DNA, controls damage to the heart under several types of stress, researchers at UT Southwestern Medical Center have found (30.3.2007)
The Genetic Signature Of Diseases: The Future Of Diagnostics -
Most of the DNA genomic sequences of organisms are now known, however those of some organisms continue to be the focus of ongoing scientific research throughout the world (11.10.2006)
Pharmacogenomic Testing and Regulation: The Role of Pharmacogenomics in Pharmaceutical Development and the Regulation of Pharmacogenetic Test as In Vitro Diagnostics -
This article reviews the current role and future trends of pharmacogenomic testing in pharmaceutical development and postmarketing surveillance (2.5.2006)
